Stereotactic Body Radiotherapy for the Management of Early-Stage Non–Small-Cell Lung Cancer: A Clinical Overview
JCO Oncology Practice · 2023-05 · 19 (5) · 239-249
DOI: 10.1200/op.22.00475 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JCO Oncology Practice, 2023-05. Verfasst von David S Buchberger und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Radiosurgery. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 81 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
ORCID-Profile: Gregory M M Videtic
Zitieren
APA
Buchberger, D. S., & Videtic, G. M. M. (2023). Stereotactic Body Radiotherapy for the Management of Early-Stage Non–Small-Cell Lung Cancer: A Clinical Overview. JCO Oncology Practice, 19(5), 239-249. https://doi.org/10.1200/op.22.00475
Vancouver
Buchberger DS, Videtic GMM. Stereotactic Body Radiotherapy for the Management of Early-Stage Non–Small-Cell Lung Cancer: A Clinical Overview. JCO Oncology Practice. 2023;19(5):239-249. doi:10.1200/op.22.00475
BibTeX
@article{Buchberger2023,
author = {Buchberger, David S and Videtic, Gregory M M},
title = {Stereotactic Body Radiotherapy for the Management of Early-Stage Non–Small-Cell Lung Cancer: A Clinical Overview},
journal = {JCO Oncology Practice},
year = {2023},
volume = {19},
number = {5},
pages = {239--249},
doi = {10.1200/op.22.00475}
}
EUVIMED